|
- Hepatitis - World Health Organization (WHO)
Hepatitis is an inflammation of the liver The condition can be self-limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer Hepatitis viruses are the most common cause of hepatitis in the world but other infections, toxic substances (e g alcohol, certain drugs), and autoimmune diseases can also cause hepatitis
- Hepatitis - World Health Organization (WHO)
Hepatitis D (HDV) is only found in people already infected with hepatitis B (HBV); however, the dual infection of HBV and HDV can cause a more serious infection and poorer health outcomes, including accelerated progression to cirrhosis Development of chronic hepatitis D is rare
- Hepatitis - World Health Organization (WHO)
Hepatitis B and C affect millions of people in the European Region Worldwide, 500 million people are estimated to be infected with hepatitis B or C These viruses kill 1 5 million people a year; 1 in every 3 people has been exposed to either or both viruses and most infected people do not know about it due to dormant symptoms
- Hepatitis A - World Health Organization (WHO)
Unlike hepatitis B and C, hepatitis A does not cause chronic liver disease but it can cause mild to severe symptoms and rarely fulminant hepatitis (acute liver failure), which is often fatal WHO estimates that in 2016, 7134 persons died from hepatitis A worldwide (accounting for 0 5% of the mortality due to viral hepatitis)
- Hepatitis - World Health Organization (WHO)
Hepatitis is an inflammation of the liver that is caused by a variety of infectious viruses and noninfectious agents Five hepatitis viruses - hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus ( HCV), hepatitis D virus (HDV) and hepatitis E virus (HEV) can infect humans and cause hepatitis
- Hepatitis E - World Health Organization (WHO)
Key facts Hepatitis E is an inflammation of the liver caused by infection with the hepatitis E virus (HEV) HEV caused 3450 deaths and there were an estimated 19 47 million cases of acute hepatitis E (AHE) globally in 2021; HEV was responsible for 5 4% of global disability-adjusted life years (DALYs) related to acute hepatitis (1)
- Hepatitis - World Health Organization (WHO)
In South-East Asia, 100 million people are currently estimated to be living with hepatitis B, and 30 million with hepatitis C In India, viral hepatitis is now recognized as a serious public health problem It places a huge disease, social and economic burden on the affected individual, family, as well as the health system
- PH must act to eliminate hepatitis - World Health Organization (WHO)
The Philippines must also continue to strengthen the hepatitis B immunization for infants and adults Current estimates indicate only 50 percent of newborn infants are administered with the hepatitis B birth dose within 24 hours after birth The hepatitis B vaccine is a cost-effective measure to prevent hepatitis B
|
|
|